KR20060123220A - 자가면역 질환 치료용 유전자를 포함하는 재조합 펩타이드벡터 - Google Patents
자가면역 질환 치료용 유전자를 포함하는 재조합 펩타이드벡터 Download PDFInfo
- Publication number
- KR20060123220A KR20060123220A KR1020067010564A KR20067010564A KR20060123220A KR 20060123220 A KR20060123220 A KR 20060123220A KR 1020067010564 A KR1020067010564 A KR 1020067010564A KR 20067010564 A KR20067010564 A KR 20067010564A KR 20060123220 A KR20060123220 A KR 20060123220A
- Authority
- KR
- South Korea
- Prior art keywords
- amino acids
- side chains
- gene
- gly
- amino acid
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 9
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 3
- 230000001225 therapeutic effect Effects 0.000 abstract 3
- 108020004414 DNA Proteins 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 abstract 1
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 abstract 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 abstract 1
- 108091036060 Linker DNA Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020067010564A KR20060123220A (ko) | 2006-05-26 | 2003-11-29 | 자가면역 질환 치료용 유전자를 포함하는 재조합 펩타이드벡터 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020067010564A KR20060123220A (ko) | 2006-05-26 | 2003-11-29 | 자가면역 질환 치료용 유전자를 포함하는 재조합 펩타이드벡터 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20060123220A true KR20060123220A (ko) | 2006-12-01 |
Family
ID=37728559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067010564A KR20060123220A (ko) | 2006-05-26 | 2003-11-29 | 자가면역 질환 치료용 유전자를 포함하는 재조합 펩타이드벡터 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20060123220A (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101486404B1 (ko) * | 2008-09-26 | 2015-01-28 | 가부시키가이샤 아오키 가가쿠겐큐쇼 | 금형용 분체 함유 유성 윤활제, 이것을 이용한 정전 도포 방법, 및 정전 도포 장치 |
-
2003
- 2003-11-29 KR KR1020067010564A patent/KR20060123220A/ko not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101486404B1 (ko) * | 2008-09-26 | 2015-01-28 | 가부시키가이샤 아오키 가가쿠겐큐쇼 | 금형용 분체 함유 유성 윤활제, 이것을 이용한 정전 도포 방법, 및 정전 도포 장치 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1339208C (en) | Fusion proteins containing a hinge region for enhanced cleavage | |
US7105638B1 (en) | Product and process for the production, isolation, and purification of recombinant polypeptide | |
JP2535066B2 (ja) | 組換え体タンパク質製造のためのリ―ダ―配列 | |
US8871907B2 (en) | Glycosylated immunoglobulin and immunoadhesin comprising the same | |
CN109963869A (zh) | 与经改造的Fc构建体相关的组合物和方法 | |
KR100227167B1 (ko) | 인체혈청알부민의 n-말단 단편을 함유하는 융합단백질 | |
EP3763734A1 (en) | Growth differentiation factor 15 (gdf-15) constructs | |
AU709134B2 (en) | Recombinant fibrin chains, fibrin and fibrin-homologs | |
CA2289912A1 (en) | Human receptor proteins; related reagents and methods | |
RU2004109222A (ru) | Слитые белки модифицированного трансферрина | |
HU215582B (hu) | Eljárás humán inzulin N-terminális szekvenciájának enzimes eltávolítására | |
EP3679068A2 (en) | CONDITIONALLY ACTIVATED BINDING MOIETIES CONTAINING Fc REGIONS | |
RU2001110120A (ru) | Модифицированный сигнальный пептид энтеротоксина-ii e. coli и микроорганизм, экспрессирующий белок слияния упомянутого пептида с гетерологичным белком | |
WO2008051505A2 (en) | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage | |
PL336295A1 (en) | Modified tnfalpha molecule, dna encoding such molecule and vaccine comprising such tnfalpha molecule and such dna | |
CN108135961A (zh) | 调控免疫反应的方法及多肽 | |
US11345745B2 (en) | Peptide-hinge-free flexible antibody-like molecule | |
Wingender et al. | Expression of human parathyroid hormone in Escherichia coli | |
EP2075336A1 (en) | Purification of recombinant proteins fused to multiple epitopes | |
CA1340906C (en) | Fibronectin binding protein as well as its preparation | |
CN107022032A (zh) | 用于调节铁稳态的组合物及其使用方法 | |
CA2261562A1 (en) | Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses | |
CN117280026A (zh) | 免疫球蛋白切割酶 | |
CA1254000A (en) | Growth hormone releasing factor analogs | |
KR20090038868A (ko) | 이염기성 b쇄 말단을 갖는 인슐린 유사체를 제조하는 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
G170 | Publication of correction | ||
WITN | Withdrawal due to no request for examination |